| Project/Area Number |
23659139
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
TAKAHAMA Kazuo 熊本大学, 大学院・生命科学研究部, 教授 (80150548)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SHIRASAKI Tetsuya 熊本大学, 大学院・生命科学研究部, 准教授 (30264047)
SOEDA Fumio 熊本大学, 大学院・生命科学研究部, 助教 (10336216)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | ヒト血漿タンパク質 / 鎮咳作用 / 難治性咳嗽 / 血液凝固 / 鎮咳薬 / コデイン / モルモット / 生体内在性咳抑制物質 / 咳嗽反射 / 下気道求心性神経放電 / 血液凝固因子 |
|---|
| Research Abstract |
A human coagulation factor XIa (F-XIa) at intravenous dose levels of ng/kg causeda potent antitussive activities on intractable coughs such as coughs occurring inACE-inhibitor treated, sub-acute bronchitic or GERD-like models of guinea pigs. It wassuggested that F-XIa itself may have a potent antitussive activity and that its activitymay be associated with a coagulation activity of F-XIa. In addition, it was suggestedthat the site of action of F-XIa may be in the periphery.
|
